HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Conn. Prop 65

This article was originally published in The Rose Sheet

Executive Summary

Toxic substances labeling proposal dies in Connecticut Public Health Committee by 12-13 vote April 3. Similar to California's Prop 65 law, S 1030 called for consumer warning labeling on products containing carcinogenic ingredients. CTFA opposed the bill with written testimony at March public hearing (1"The Rose Sheet" March 19, p. 3). Legislation was supported by Attorney General Richard Blumenthal

You may also be interested in...



CTFA Toluene Safety Substantiation To Follow Conn. Prop 65 Clone Hearing

The Cosmetic, Toiletry and Fragrance Association will defend the safety of nail polish ingredient toluene in an upcoming statement to the Connecticut Public Health Committee after the ingredient was targeted as an unsafe toxin during a Prop 65 clone hearing in Hartford, Conn. March 15.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

UsernamePublicRestriction

Register

RS009129

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel